N

NextCure Inc
F:2US

Watchlist Manager
NextCure Inc
F:2US
Watchlist
Price: 4.728 EUR Market Closed
Market Cap: 131.9m EUR

Wall Street
Price Targets

2US Price Targets Summary
NextCure Inc

Wall Street analysts forecast 2US stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 2US is 7.37 EUR with a low forecast of 6.196 EUR and a high forecast of 8.589 EUR.

Lowest
Price Target
6.196 EUR
31% Upside
Average
Price Target
7.37 EUR
56% Upside
Highest
Price Target
8.589 EUR
82% Upside
NextCure Inc Competitors:
Price Targets
ORGO
Organogenesis Holdings Inc
52% Upside
FHTX
Foghorn Therapeutics Inc.
97% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
30% Upside
NTRA
Natera Inc
4% Upside
AUPH
Aurinia Pharmaceuticals Inc
6% Upside
ALNY
Alnylam Pharmaceuticals Inc
22% Upside
EXEL
Exelixis Inc
0% Downside
PRTA
Prothena Corporation PLC
114% Upside

Revenue
Forecast

Revenue Estimate
NextCure Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
NextCure Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
NextCure Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 2US's stock price target?
Price Target
7.37 EUR

According to Wall Street analysts, the average 1-year price target for 2US is 7.37 EUR with a low forecast of 6.196 EUR and a high forecast of 8.589 EUR.

Back to Top